# Effect of EPA and HMB on Strength in ICU Patients

> **NCT01270516** · NA · COMPLETED · sponsor: **Gerald Supinski** · enrollment: 73 (actual)

## Conditions studied

- Muscle Weakness

## Interventions

- **DRUG:** HMB, hydroxymethylbutyrate
- **DRUG:** EPA, eicosapentaenoic acid
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01270516
- **Lead sponsor:** Gerald Supinski
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2020-01-20
- **Final completion:** 2020-01-20
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2021-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270516, "Effect of EPA and HMB on Strength in ICU Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01270516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*